Perfil
Dorrit T.
Andersen is currently working as a Regulatory Director at Galecto Biotech ApS.
Prior to this, she worked as a Director-Global Regulatory Affairs at Novo Nordisk A, Manager-Regulatory Affairs at Genmab A and Symphogen A, and Head-Regulatory Affairs at Ciba-Geigy Denmark.
Andersen completed her undergraduate degree at the University of Copenhagen.
Cargos activos de Dorrit T. Andersen
| Empresas | Cargo | Inicio |
|---|---|---|
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Consejero General | - |
Antiguos cargos conocidos de Dorrit T. Andersen.
| Empresas | Cargo | Fin |
|---|---|---|
Ciba-Geigy Denmark | Consejero General | - |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Consejero General | - |
| GENMAB A/S | Consejero General | - |
| NOVO NORDISK A/S | Consejero General | - |
Formación de Dorrit T. Andersen.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Ciba-Geigy Denmark | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
- Bolsa de valores
- Insiders
- Dorrit T. Andersen
















